Taysha Gene Therapies
TSHA
#7197
Rank
NZ$0.62 B
Marketcap
$3.06
Share price
2.25%
Change (1 day)
-28.17%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.23 Billion

According to Taysha Gene Therapies's latest financial reports the company has NZ$0.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.24 B8.31%
2023-12-31NZ$0.22 B64.44%
2022-12-31NZ$0.13 B-36.59%
2021-12-31NZ$0.21 B-37.31%
2020-12-31NZ$0.34 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.43 B 84.10%๐Ÿ‡บ๐Ÿ‡ธ USA